Dow Up 1.13% Nasdaq Up 1.41%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
8.53 Up 0.06(0.71%) 4:00PM EDT
|After Hours : 8.53 0.00 (0.00%) 4:27PM EDT
Prev Close:8.47
Open:8.57
Bid:8.45 x 200
Ask:8.65 x 500
1y Target Est:7.67
Beta:0.65
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:8.46 - 8.59
52wk Range:7.22 - 10.26
Volume:2,131,822
Avg Vol (3m):3,205,880
Market Cap:1.37B
P/E (ttm):5.16
EPS (ttm):1.65
Div & Yield:0.60 (7.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 0.71%1.37B
AMGNUp 0.37%123.42B
SGENUp 4.03%4.53B
XOMADown 6.13%459.36M

Key Statistics

Forward P/E (1 yr):3.52
P/S (ttm):3.10
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.08
Quarterly EPS Est (Sep-14) :0.56
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback